ERBB2 and metastatic malignant neoplasm in the lymph nodes: Similarly to the present study, Soria et al. demonstrated that ERBB2 overexpression was associated with pathologic characteristics, such as a more advanced T stage, high-grade tumors, and the presence of lymph node metastasis, lymphovascular invasion, and tumor necrosis [24].